Equivalent device of Triamcinolone Acetonide nasal spray is NOW available!

NEMERA NEWS

Following the extension of its Bioequivalence program, Nemera is pleased to announce the availability of Generic “Triamcinolone Acetonide” delivery system, composed of:

  • SP270+ pump
  • 8471 actuator
  • Cap
  • Anti-actuation clip

With spray expertise, regulatory experts and laboratory testing capabilities, Nemera is able to support your development by performing preliminary testing with your formulation following the EMA and FDA requirements.

generique-nasacort-tube-blanc

SP270+ screw-on (GCMI 18-415) is a reference in consistency and reliability

Key molecules with Bioequivalent performance to the originator available for generic markets are:

  • Mometasone furoate
  • Fluticasone propionate
  • Triamcinolone acetonide

For further information about the Nemera Device Equivalence program, contact us at pascale.farjas@nemera.net.

spotlight-bioeq-nasacort_post-news


Attached documents:


About Nemera

Nemera is a world leader in the design, development and manufacturing of drug delivery solutions. Its expertise covers all five modes of delivery: Nasal/Buccal/Auricular (spray pumps, actuators, valves, etc.), Ophthalmic (preservative-free multidose eyedroppers), Parenteral (autoinjectors, pens, safety devices & implanters), Pulmonary (pMDIs, DPIs), Dermal /Transdermal (airless & atmospheric dispensers). Nemera provides solutions for the pharmaceutical industry, including standard innovative products, the development of proprietary devices and contract manufacturing.